Table 1.
Basic data of patients, participating in the study.
| No. of patients | Age (years) | Gender |
Initial blood Glucose level (mg/dl) |
Initial HbA1c- blood level (%) |
Medicatio n a |
|---|---|---|---|---|---|
| 1 | 52 | F | 96 | 6,3 | MF |
| 2 | 64 | M | 190 | 6,0 | MF |
| 3 | 29 | M | 164 | 6,9 | MF, DPI, IN |
| 4 | 66 | M | 100 | 6,4 | MF, DPI |
| 5 | 62 | F | 119 | 6,7 | |
| 6 | 62 | F | 134 | 6,5 | |
| 7 | 69 | F | 138 | 7,6 | |
| 8 | 61 | M | 136 | 7,6 | MET, GLP |
| 9 | 65 | M | 118 | 6,3 | MET |
| 10 | 72 | M | 178 | 7,0 | IN |
| 11 | 67 | M | 170 | 7,1 | MET, IN |
| 12 | 52 | M | 193 | 7,1 | GLP, IN |
| 13 | 60 | M | 179 | 7,2 | IN |
| 14 | 57 | M | 135 | 7,3 | MET |
| 15 | 49 | F | 158 | 6,5 | DPI, IN |
| 16 | 43 | M | 134 | 6,9 | MET |
| 17 | 77 | M | 147 | 7,4 | MET |
| 18 | 60 | M | 141 | 6,3 | MET |
| 19 | 62 | F | 94 | 5,8 | MET |
| 20 | 69 | M | 186 | 7,2 | MET, GLP, IN |
aMET = metformin; DPI= DPP4-inhibitor, GLP1= receptor antagonist; IN= insulin